This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Analysts' Actions: ARNA, F, BRCM, QCOM

NEW YORK (TheStreet) -- CHANGE IN RATINGS

Actuant (ATU) downgraded at Citigroup to Neutral from Buy, Citigroup said. $29 price target. More balanced risk/reward outlook.

Broadcom (BRCM) rated new Buy at Cantor. $40 price target. Infrastructure business trends remain strong and the NetLogic purchase should boost growth.

Dolby (DLB) rated new Sell at Goldman. $39 price target. Company faces multiple growth headwinds.

Ford Motor (F) rated new Hold at Stifel. Company had been losing market share but is now better positioned for the next major product cycle.

First Niagara (FNFG) upgraded at BofA/Merrill from Neutral to Buy, Bank of America/Merrill Lynch said. $9 price target. Stock appears oversold and sports a 4% dividend yield.

Gartner (IT) rated new Market Perform at Wells. IT was initiated with a Market Perform rating, Wells Fargo said. Company is leveraged to near-term IT spending concerns.

LKQ (LKQ) downgraded at Baird from Outperform to Neutral, Robert Baird said. Valuation call, based on a $37 price target.

McGraw-Hill (MHP) upgraded at Benchmark from Hold to Buy, Benchmark said. $53 price target. Company has strong growth prospects in finance and can unlock value by separating the education business.

Microsemi (MSCC) upgraded at Wells from Market Perform to Outperform, Wells Fargo said. Valuation call, following the recent pullback.

Qualcomm (QCOM) rated new Buy at Cantor Fitzgerald. $66 price target. Long-term trends remain positive for wireless devices.

Riverbed (RVBD) rated new Strong Buy at Needham. $25 price target. Stock looks oversold at current levels.

Spectra Energy (SE) upgraded at UBS to Buy from Neutral, UBS said. $31 price target. Prices already reflect NGL weakness.

Veeco Instruments (VECO) rated new Equal-weight at Piper. Overall market outlook remains uncertain.

Western Gas Partners (WES) upgraded at UBS to Buy from Neutral, UBS said. $48 price target. Continue to expect strong distribution growth.

Xylem (XYL) downgraded at Goldman to Sell, Goldman Sachs said. $24 price target. Company is leveraged to softer European and municipal water markets.

STOCK COMMENTS / EPS CHANGES

Arena Pharmaceuticals (ARNA) numbers increased at BMO. ARNA estimates were raised through 2013, BMO Capital said. Company received better labeling in its FDA approval. Market Perform rating and new $12 price target.

Arena Pharmaceuticals target raised at Jefferies. Shares of ARNA now seen reaching $20, Jefferies said. FDA approves Lorcaserin. Buy rating.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,948.08 +28.49 0.17%
S&P 500 1,983.69 +2.09 0.11%
NASDAQ 4,528.6110 +1.0970 0.02%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs